Motilal Oswal
  • SENSEX
    NIFTY 50
Motilal Oswal
January 02, 2019 09:29 AM IST | Healthcare

Why biosimilars are a huge opportunity for the Indian biopharmaceutical industry

The global biosimilars market is estimated to touch $15 billion by 2020.
There is increased activity and growth in the biosimilars market globally with some of the best-selling biologics going off-patent.
To meet its global aspirations as a vital supplier of biosimilars, India must address some of the fundamental concerns that investors have about the Indian legal and regulatory framework for biopharmaceuticals.
Why biosimilars are a huge opportunity for the Indian biopharmaceutical industry
Published Date: Jan 2nd, 2019 09:29 AM | Updated Date: January 02, 2019 09:29 AM IST
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV